Rapid resolution of severe retinal neovascularisation in proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab (Avastin).
A 23-year-old aboriginal woman with severe bilateral proliferative diabetic retinopathy and left rubeotic glaucoma received bilateral pan-retinal photocoagulation with adjunctive intravitreal bevacizumab. Six days post-injection, there was almost complete resolution of new vessels.
Thew
Michael
M
Ophthalmology Department, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. mrjthew@ausdoctors.net
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003131:Combined Modality Therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007267:Injections; D008028:Light Coagulation; D015861:Retinal Neovascularization / Q000188:drug therapy*; D012720:Severity of Illness Index; D014822:Vitreous Body; D055815:Young Adult
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab